Adenosine triphosphate prevents serum deprivation-induced apoptosis in human mesenchymal stem cells via activation of the MAPK signaling pathways

Stem Cells

Volumn 33, Issue 1, 2015, Pages 211-218

  Berlier, Jessica L ^a   Rigutto, Sabrina ^a   Dalla Valle, Antoine ^a   Lechanteur, Jessica ^a   Soyfoo, Muhammad S ^a,b   Gangji, Valerie ^a   Rasschaert, Joanne ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Apoptosis; ATP; Human mesenchymal stem cells; MAPK pathways; Serum deprivation

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE 3; CASPASE 7; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAD; CULTURE MEDIUM;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL ISOLATION; CELL SURVIVAL; CELL THERAPY; CELL VIABILITY; CULTURE MEDIUM; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MESENCHYMAL STEM CELL; NONHUMAN; PRION DISEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; WESTERN BLOTTING; ADOLESCENT; ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

BOVINAE;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; APOPTOSIS; CASPASE 3; CASPASE 7; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; HUMANS; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; YOUNG ADULT;

EID: 84919457307     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1831     Document Type: Article

References (48)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal Stem Cells. Science 1999; 284: 143-147.
2. Bieback K, Kern S, Klüter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004; 22: 625-634.
3. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279-4295.
4. Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006; 24: 1294-1301.
5. Chamberlain G, Fox J, Ashton B, et al. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749.
6. Hare JM, Traverse JH, Henry TD, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am Coll Cardiol 2009; 54: 2277-2286.
7. Pittenger MF, Martin BJ,. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004; 95: 9-20.
8. Dantuma E, Merchant S, Sugaya K,. Stem cells for the treatment of neurodegenerative diseases. Stem Cell Res Ther 2010; 1: 37.
9. Beyth S, Schroeder J, Liebergall M,. Stem cells in bone diseases: Current clinical practice. Br Med Bull 2011; 99: 199-210.
10. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309-313.
11. Hauzeur J-P, Gangji V,. Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells Int 2010; 26: 410170.
12. Pagán JA, Postigo I, Rodríguez-Pacheco JR, et al. Bovine serum albumin contained in culture medium used in artificial insemination is an important anaphylaxis risk factor. Fertil Steril 2013; 90: e17-2013.e19.
13. Selvaggi TA, Walker RE, Fleisher TA,. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 1997; 89: 776-779.
14. Tonti GA, Mannello F. From bone marrow to therapeutic applications: Different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol 2008; 52: 1023-1032.
15. Dimarakis I, Levicar N,. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells 2006; 24: 1407-1408.
16. Zhu W, Chen J, Cong X, et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006; 24: 416-425.
17. Vicente Lopez MA, Vazquez Garcia MN, Entrena A, et al. Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency. Stem Cells Dev 2011; 20: 1011-1019.
18. Solmesky LJ, Abekasis M, Bulvik S, et al. Bone morphogenetic protein signaling is involved in human mesenchymal stem cell survival in serum-free medium. Stem Cells Dev 2009; 18: 1283-1292.
19. Corriden R, Insel PA,. Basal release of ATP: An autocrine-paracrine mechanism for cell regulation. Sci Signal 2011; 3: re1.
20. Fitz JG,. Regulation of cellular ATP release. Trans Am Clin Climatol Assoc 2007; 118: 199-208.
21. Ayna G, Krysko D V, Kaczmarek A, et al. ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophages. Plos One 2012; 7: e40069.
22. Piccini A, Carta S, Tassi S, et al. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 2008; 105: 8067-8072.
23. Orriss IR, Knight GE, Utting JC, et al. Hypoxia stimulates vesicular ATP release from rat osteoblasts. J Cell Physiol 2009; 220: 155-162.
24. Ralevic V, Burnstock G,. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-492.
25. Burnstock G,. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Bioessays 2012; 34: 218-225.
26. Burnstock G,. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797.
27. Ferrari D, Gulinelli S, Salvestrini V, et al. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. Exp Hematol 2011; 39: 360-374.
28. Ciciarello M, Zini R, Rossi L, et al. Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. Stem Cells Dev 2013; 22: 1097-1111.
29. Vaughan KR, Stokes L, Prince LR, et al. Inhibition of neutrophil apoptosis by ATP is mediated by the P2Y11 receptor. J Immunol 2007; 179: 8544-8553.
30. Urban D, Härtel F V, Gadiraju K, et al. Extracellular ATP attenuates ischemia-induced caspase-3 cleavage in human endothelial cells. Biochem Biophys Res Commun 2012; 425: 230-236.
31. Arthur DB, Georgi S, Akassoglou K, et al. Inhibition of apoptosis by P2Y2 receptor activation: Novel pathways for neuronal survival. J Neurosci 2006; 26: 3798-3804.
32. Hoppe J, Schäfer R, Hoppe V, et al. ATP and adenosine prevent via different pathways the activation of caspases in apoptotic AKR-2B fibroblasts. Cell Death Differ 1999; 6: 546-556.
33. Minamide LS, Bamburg JR,. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal Biochem 1990; 190: 66-70.
34. Abbracchio MP, Burnstock G, Boeynaems J, et al. International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology. Pharmacol Rev 2006; 58: 281-341.
35. Ode A, Schoon J, Kurtz A, et al. CD73/5'-ecto-nucleotidase acts as a regulatory factor in osteo-/chondrogenic differentiation of mechanically stimulated mesenchymal stromal cells. Eur Cell Mater 2013; 25: 37-47.
36. Henderson YC, Chen Y, Frederick MJ, et al. MEK inhibitor PD0325901 significantly reduces the growth of papillary thyroid carcinoma cells in vitro and in vivo. Mol Cancer Ther 2010; 9: 1968-1976.
37. Callus BA, Moujallad DM, Silke J, et al. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins. J Mol Biol 2008; 384: 313-323.
38. Vanbrocklin MW, Verhaegen M, Soengas MS, et al. Mitogen-activated protein kinase inhibition induces translocation of bmf to promote apoptosis in melanoma. Cancer Res 2009; 69: 1985-1994.
39. Bergfeld GR, Forrester T,. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992; 26: 40-47.
40. Schnoke M, Midura SB, Midura RJ,. Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair. Bone 2009; 45: 590-602.
41. Savill JS, Wyllie AH, Henson JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation. J Clin Invest 1989; 83: 865-875.
42. Lu Z, Xu S,. ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 2006; 58: 621-631.
43. Mebratu Y, Tesfaigzi Y,. How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer? Cell Cycle 2009; 8: 1168-1175.
44. Youle RJ, Strasser A,. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
45. Yang E, Zha J, Jockel J, et al. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
46. Cheng EH-YA, Wei MC, Weiler S, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-711.
47. Wong WW-L, Puthalakath H,. Bcl-2 family proteins: The sentinels of the mitochondrial apoptosis pathway. IUBMB Life 2008; 60: 390-397.
48. Bulavin DV, Saito S, Hollander MC, et al. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 1999; 18: 6845-6854.